QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (96) Citing Articles via Google Scholar Google Scholar Articles by Klivenyi, P. Articles by Beal, M. F. Search for Related Content PubMed PubMed Citation Articles by Klivenyi, P. Articles by Beal, M. F.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 2000, 20(1):1-7

Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

Peter Klivenyi¹, Ole A. Andreassen¹, Robert J. Ferrante², Alpaslan Dedeoglu², Gerald Mueller¹, Eric Lancelot¹, Mikhail Bogdanov¹, Julie K. Andersen³, Dongmei Jiang³, and M. Flint Beal^{1, 4}

¹ Neurology Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, ² Departments of Neurology, Pathology, and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, and the Department of Veterans Affairs, Bedford, Massachusetts, ³ Department of Gerontology, University of Southern California, Los Angeles, California, and ⁴ Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York 10021

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Glutathione peroxidase (GSHPx) is a critical intracellular enzyme involved in detoxification of hydrogen peroxide (H₂O₂) to water. In the present study we examined the susceptibility of mice with a disruption of the glutathione peroxidase gene to the neurotoxic effects of malonate, 3-nitropropionic acid (3-NP), and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Glutathione peroxidase knock-out mice showed no evidence of neuropathological or behavioral abnormalities at 2-3 months of age. Intrastriatal injections of malonate resulted in a significant twofold increase in lesion volume in homozygote GSHPx knock-out mice as compared to both heterozygote GSHPx knock-out and wild-type control mice. Malonate-induced increases in conversion of salicylate to 2,3- and 2,5-dihydroxybenzoic acid, an index of hydroxyl radical generation, were greater in homozygote GSHPx knock-out mice as compared with both heterozygote GSHPx knock-out and wild-type control mice. Administration of MPTP resulted in significantly greater depletions of dopamine, 3,4-dihydroxybenzoic acid, and homovanillic acid in GSHPx knock-out mice than those seen in wild-type control mice. Striatal 3-nitrotyrosine (3-NT) concentrations after MPTP were significantly increased in GSHPx knock-out mice as compared with wild-type control mice. Systemic 3-NP administration resulted in significantly greater striatal damage and increases in 3-NT in GSHPx knock-out mice as compared to wild-type control mice. The present results indicate that a knock-out of GSHPx may be adequately compensated under nonstressed conditions, but that after administration of mitochondrial toxins GSHPx plays an important role in detoxifying increases in oxygen radicals.

Key words: MPTP; 3-nitropropionic acid; malonate; oxidative damage; free radicals; glutathione; Parkinson's; Huntington's

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The formation of hydrogen peroxide and related oxygen radicals is suspected to be involved in the mechanism of nerve cell death and in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease (Coyle and Puttfarcken, 1993; Beal, 1995). There is substantial evidence that the brain, which consumes large amounts of oxygen, is particularly vulnerable to oxidative damage. The relative roles of endogenous and exogenous antioxidants in protecting the brain against oxidative stress are still being clarified. The major antioxidant defenses consist of antioxidant scavengers such as glutathione, vitamin C, vitamin E, and antioxidant enzymes.

The antioxidant enzymes in the brain include Cu,Zn- and manganese superoxide dismutase, which catalyze the conversion of O₂ to H₂O₂ (Fridovich, 1989). H₂O₂ is then converted to H₂O by either catalase or selenoglutathione peroxidases. Catalase is thought to be relatively low in the brain and is localized to peroxisomes (Gaunt and De Duve, 1976; Halliwell, 1992). The selenoglutathione peroxidases include the "classic" enzyme selenoglutathione peroxidase-I (GSHPx; GSH:H₂O₂ oxidoreductase, EC 1.11.19) and a more recently characterized phospholipid hydroperoxide glutathione peroxidase (Fisher et al., 1999). Among the brain glutathione peroxidases, only GSHPx is known to reduce H₂O₂, indicating that GSHPx may be a major protective enzyme against the action of H₂O₂ in the brain (Jain et al., 1991). Recent evidence showed that GSHPx also plays a major role in detoxifying peroxynitrite (ONOO) (Sies et al., 1997). GSHPx is present both in the cytosol and in mitochondria (Vitorica et al., 1984), which are a major intracellular source of free radicals (Boveris and Chance, 1973).

Malonate and 3-nitropropionic acid (3-NP) are inhibitors of succinate dehydrogenase, which model Huntington's disease (Beal et al., 1993a,b). 1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) has been extensively used to replicate the dopaminergic neuronal loss occurring in Parkinson's disease (Bloem et al., 1990). Its active metabolite 1-methyl-4-phenylpyridinium (MPP⁺) selectively inhibits mitochondrial complex I activity (Tipton and Singer, 1993). These neurotoxins produce impaired energy metabolism and oxidative stress, which plays a direct role in neuronal injury. We and others observed an increased formation of oxygen-derived free radicals when neurons were challenged with malonate, 3-NP, MPTP, or MPP⁺ (Hasegawa et al., 1990; Chiueh et al., 1992; Schulz et al., 1995a; Sriram et al., 1997; Huang and Lee, 1998).

In the present study, we investigated the importance of the glutathione system in protecting the brain from mitochondrial toxins. Our hypothesis was that an impairment of GSHPx activity, which may be compensated when occurring in isolation, may lead to irreversible cell loss when combined with increased free radical generation caused by mitochondrial toxins. Specifically, we sought to determine if GSHPx knock-out mice would be more sensitive to malonate, 3-NP, or MPTP toxicity than control mice.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Experimental animals. Our experiments were approved by the local Animal Care Committee and were conducted in strict accordance with the National Institutes of Health guidelines for the care and use of experimental animals. All chemicals were purchased from Sigma (St. Louis, MO) unless otherwise indicated. Mice (2- to 3-months-old) were in a B6C3F1 background. The wild-type controls were obtained from Taconic (Germantown, NY), whereas those deficient in cellular GSHPx were provided by Dr. Julie Andersen, University of Southern California (Los Angeles, CA) and bred locally. We bred the GSHPx homozygote mice with the BGC3F1 mice to produce heterozygote GSHPx knock-out mice for use as a further control for genetic background effects. The GSHPx knock-out mice were generated as previously described (Ho et al., 1997) by insertion of a neomycin resistance gene cassette into the EcoRI site located in exon 2 of the GSHPx mouse gene. This introduces a BamHI site into exon 2, which gives a 4.3 kb band on Southern blot analysis instead of the 11 kb band found in the normal controls. A herpes thymidine kinase gene cassette was placed at a second EcoRI site in the 3' untranslated region for positive-negative selection with G418/gangcyclovir in embryonic stem cells. These mice show an 85% reduction in cortex GSHPx activity from 0.155 ± 0.021 to 0.024 ± 0.017, p < 0.001 as previously described (Lawrence and Burk, 1976).

Intrastriatal microinjections. Control (n = 10), heterozygote GSHPx knock-out mice (n = 10), and homozygous and GSHPx knock-out (n = 12) mice were anesthetized with methoxyflurane and malonate (1.4 µmol in 0.7 µl, pH 7.4) that was stereotaxically injected into the left striatum (anterior, 0.5 mm; lateral, 2 mm from bregma; ventral, 3.5 mm from dura). The injections were performed over 2 min using a 10 µl 26 gauge blunt-tipped Hamilton syringe. The needle was left in place for 5 min before being slowly withdrawn. Seven days after striatal injection animals were killed, and the brains were rapidly removed, placed in cold saline, and sectioned coronally at 1 mm intervals. Slices were stained in 2% 2,3,5-triphenyltetrazolium chloride monohydrate solution at room temperature in the dark for 30 min, and post-fixed in phosphate-buffered 4% paraformaldehyde (PFA) (Bederson et al., 1986). The lesioned area (noted by pale staining) was measured on the posterior surface of each section using Neurolucida (Microbrightfield, Colchester, VT) image analysis software. We previously showed that these measurements exhibit no significant differences from those obtained with Nissl staining (Schulz et al., 1995a). Lesion volumes (mean ± SEM) were calculated by multiplying the lesion area by the slice thickness.

Salicylate assay and 3-nitrotyrosine measurement. The salicylate hydroxyl radical trapping method was used for measuring levels of OH radicals in striatal tissue after injection of malonate in control (n = 13), GSHPx heterozygote knock-out (n = 13), and homozygous GSHPx knock-out (n = 11) mice (Floyd et al., 1984). Salicylate (200 mg/kg, 5 ml/kg, i.p.) was administered 30 min before striatal malonate injection. Sixty minutes after malonate injection, the animals were killed, and the left and right striata were rapidly dissected from a 2-mm-thick slice on a chilled glass plate and immediately frozen at 70°C. To examine the effects of 3-NP on 3-NT levels, control (n = 8) and GSHPx knock-out (n = 8) mice received six doses of 50 mg/kg intraperitoneally at 12 hr intervals. Mice were killed 1 hr after the last dose. The striata were rapidly dissected and placed in chilled 0.1 M perchloric acid. The samples were thawed in 0.25 ml of chilled 0.1 M perchloric acid, sonicated, and centrifuged twice. Salicylate and its metabolites 2,3- and 2,5-dihydroxybenzoic acid (DHBA), tyrosine, and 3-NT were quantified in the supernatant by HPLC with 16-electrode electrochemical detection (Beal et al., 1990). Data (mean ± SEM) were expressed as the ratio of 2,3- and 2,5-DHBA to salicylate and of 3-NT to tyrosine to normalize for varying brain concentrations of salicylate and tyrosine.

Dopamine measurement. MPTP (15 mg/kg, 5 ml/kg, i.p.) was administered four times at 2 hr intervals to control (n = 10) and GSHPx knock-out (n = 10) mice. An additional set of animals of each type was also treated with 0.1 M PBS (5 ml/kg, i.p.) at the times of MPTP injections. The animals were killed at 1 week, and both striata were rapidly dissected on a chilled glass plate and frozen at 70°C. The samples were subsequently thawed in 0.25 ml of chilled 0.1 M perchloric acid and sonicated. Aliquots were taken for protein quantification using a fluorometric assay (Beal et al., 1990). Other aliquots were centrifuged, and dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) were measured in supernatants by HPLC and electrochemical detection. Concentrations of dopamine and metabolites were expressed as nanograms per milligram of protein (mean ± SEM).

MPP⁺ levels. To determine whether MPTP uptake or metabolism was altered, MPTP 20 mg/kg was administered intraperitoneally twice, 2 hr apart, and mice were killed 2 hr after the last dose (n = 8/group). Striatal tissue from this experiment was also used for 3-NT determinations. MPP⁺ levels were quantified by HPLC with UV detection at 295 nm. Samples were sonicated in 0.1 M perchloric acid, and an aliquot of supernatant was injected onto a Brownlee aquapore X03-224 cation exchange column (Rainin, Woburn, MA). Samples were eluted isocratically with 90% 0.1 M acetic acid and 75 mM triethylamine HCl, pH 2.3, adjusted with formic acid and 10% acetonitrile.

Histological study. 3-NP (50 mg/kg, 5 ml/kg, i.p.) was administered eight times at 12 hr intervals to control (n = 8) and GSHPx knock-out (n = 9) mice. An additional set of animals of each type was also treated with 0.1 M PBS (5 ml/kg, i.p.) at the times of 3-NP injections. Twelve hours after the last injection, the animals were deeply anesthetized with pentobarbital and perfused with ice-cold 0.9% saline followed by 4% paraformaldehyde. Brains were post-fixed for 1 hr, rinsed in 0.1 M PBS, and then cryoprotected in a graded series of 10% and 20% glycerol/2% DMSO solution. Frozen brains were sectioned at 50 µm using a sledge microtome and Nissl-stained as previously described (Beal et al., 1989). Bilateral striatal lesion volumes were computed in serial sections through the rostrocaudal extent of each brain by videomicroscopic capture of brain sections and subsequent volume analysis using Neurolucida (Microbrightfield) image analysis software.

Statistical analysis. Results are expressed as the mean ± SEM. Statistical comparisons were made using Student's t test (unpaired) or one-way ANOVA followed by Fisher's PLSD post hoc tests.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The lesion volumes after intrastriatal injection of malonate in wild-type controls and GSHPx knock-out mice are shown in Figure 1. Lesion volumes after malonate injections were significantly larger in homozygous GSHPx compared to both heterozygous GSHPx (p < 0.01) and wild types (p < 0.001). There was no significant difference between heterozygous GSHPx knock-out and wild-type mice. Injection of vehicle resulted in negligible lesions in both controls and GSHPx knock-out mice (0.24 ± 0.04 vs 0.34 ± 0.07 mm³). After administration of salicylate, intrastriatal injection of malonate resulted in a significant increase in 2,3 DHBA compared to the unlesioned side only in homozygous GSHPx knock-out mice (p < 0.001) (Fig. 2). The level of 2,3 DHBA in the lesioned side of homozygous GSHPx knock-out was significantly higher than in the lesioned side in both heterozygous GSHPx knock-out and wild types (p < 0.001). A significant increase in 2,5 DHBA was seen in the lesioned striata in all groups, but the increase in homozygous GSHPx knock-out was significantly larger than the increase in both heterozygous GSHPx knock-out and the wild-type mice (p < 0.0001). There was no significant difference between heterozygous GSHPx knock-out and wild-type mice.

View larger version (24K): [in this window] [in a new window]   Figure 1.   Malonate induced striatal lesion volumes in wild-type controls, heterozygote, and homozygote GSHPx knock-out mice. **p < 0.01, as compared with controls; #p < 0.05, as compared with heterozygote GSHPx knock-out mice.

View larger version (25K): [in this window] [in a new window]   Figure 2.   Malonate induced increases in the conversion of salicylate to 2,3 and 2,5-DHBA in wild-type controls, heterozygote, and homozygote GSHPx knock-out mice. *p < 0.001, as compared with the uninjected striatum; #p < 0.001, as compared with heterozygote GSHPx knock-out and wild-type controls.

The effects of administration of MPTP in wild-type control and GSHPx knock-out mice are seen in Figure 3. We used a relatively low dose of MPTP, 4 × 15 mg/kg, which produced a small significant dopamine depletion of 15% in wild-type controls. In contrast, the same dose of MPTP produced a significant 61% depletion of dopamine in GSHPx knock-out mice that was significantly, p < 0.001, greater than that seen in controls. Depletions of DOPAC and HVA in controls did not reach significance, but they were highly significant in GSHPx knock-out mice and were significantly (p < 0.001) greater than those seen in wild-type controls. The increased sensitivity to MPTP was not caused by an alteration in uptake or metabolism of MPTP to MPP⁺ because striatal MPP⁺ levels did not significantly differ at 2 hr after MPTP administration (MPP⁺ 8.4 ± 1.3 ng/mg protein in controls and 9.5 ± 1.0 ng/mg protein in GSHPx knock-out mice). The effects of MPTP on striatal 3-NT levels are shown in Figure 4. MPTP administration in the GSHPx knock-out mice resulted in a significant increase in 3-NT levels as compared with wild-type controls (p < 0.01). We previously found that saline-injected controls had 3-NT levels of 1-2 3-NT/1000 tyrosines (Schulz et al., 1995b), consistent with the findings in Figure 6.

View larger version (50K): [in this window] [in a new window]   Figure 3.   Effects of MPTP administered at 15 mg/kg X4 on dopamine, DOPAC, and HVA in wild-type control and GSHPx knock-out mice. *p < 0.05, ***p < 0.001, as compared to PBS-treated animals; ##p < 0.01, ###p < 0.001, as compared to wild-type treated with MPTP.

View larger version (19K): [in this window] [in a new window]   Figure 4.   Effects of MPTP 20 mg/kg X2 on striatal 3-NT levels 2 hr after MPTP administration in wild-type control and GSHPx knock-out mice. **p < 0.01, as compared with wild-type controls.

Systemic administration of 3-NP resulted in bilateral striatal lesions in both wild-type controls and GSHPx knock-out mice (Fig. 5). The areas of neuronal loss and increased gliosis within the caudate putamen were significantly (almost fourfold) greater in the GSHPx knock-out mice (Fig. 5). Striatal lesion volumes were 3.72 ± 0.26 mm³ in controls and 14.12 ± 0.92 mm³ in GSHPx knock-out mice, p < 0.01. The effects of 3-NP on 3-NT levels are shown in Figure 6. 3-Nitrotyrosine levels increased after 3-NP administration in both controls and GSHPx knock-out mice, but the increases were significantly (p < 0.05) greater in the GSHPx knock-out mice than those observed in the controls.

View larger version (120K): [in this window] [in a new window]   Figure 5.   Photomicrographs of 3-NP lesions in Nissl-stained whole-brain sections through the striatum of wild-type (A) and glutathione peroxidase knock-out (B) mice. Bilateral striatal lesions are present in both A and B and are represented by staining pallor in the lateral aspect (arrows). The lesions are significantly larger in the glutathione peroxidase knock-out mouse. Scale bar, 2 mm.

View larger version (40K): [in this window] [in a new window]   Figure 6.   Effects of 3-NP on 3-NT levels in wild-type control and GSHPx knock-out mice. **p < 0.01, ***p < 0.001, as compared with PBS; #p < 0.05, as compared with wild-type control.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The glutathione (GSH) system plays a major role in controlling cellular redox states and is a primary defense mechanism for H₂O₂ and peroxide removal in brain. Immunocytochemical studies showed localization of GSHPx to both brain astrocytes and neurons (Damier et al., 1993; Olanow, 1993; Trepanier et al., 1996). In cultured cerebellar astrocytes, cytosolic GSH and GSHPx were 57 and 245% higher than those found in granule cells (Huang and Philbert, 1995). Other studies also showed increased GSH in astrocytes as compared to neurons (Slivka et al., 1987; Raps et al., 1989). The ratio of mitochondrial to cytosolic GSH and mitochondrial GSHPx however is higher in cerebellar granule cells than astrocytes, suggesting that the GSHPx system may be particularly important in neuronal mitochondria. Depletion of GSH leads to mitochondrial damage and reductions in mitochondrial enzymes in brain (Jain et al., 1991; Martinez et al., 1995), and it causes calcium-mediated cell death in PC12 cells (Jurma et al., 1997). Further evidence implicating GSH in normal brain function are the observations that glutathione depletion in vivo results in dystrophic axons in dopaminergic neurons and enhances the neurotoxicity of ischemia, 6-hydroxydopamine, MPP⁺, and MPTP (Pileblad et al., 1989; Mizui et al., 1992; Andersen et al., 1996; Wullner et al., 1996; Nakamura et al., 1997).

The fact that mice with a knock-out of GSHPx show no neuronal degeneration up to 3 months of age is, therefore, somewhat surprising. It is, however, consistent with a previous report that mice deficient in cellular GSHPx develop normally, are fertile, and show no increase in lung toxicity to hyperoxia (Ho et al., 1997). Histological examination at 4 and 15 months of age was normal in all tissues, including the brain, and protein carbonyls and lipid peroxidation products were unaltered from controls (Ho et al., 1997). These observations suggest an alternative means of removing H₂O₂ under baseline physiological conditions. Although catalase activity (EC 1.11.16) was reported to be low in the brain, it is widely distributed throughout the brain (Gaunt and De Duve, 1976; Brannan et al., 1981). Both catalase and GSHPx are found in cultured astrocytes (Copin et al., 1992; Huang and Philbert, 1995; Desagher et al., 1996). H₂O₂ easily crosses cell membranes and therefore could leave the cell to damage neighboring cells or be detoxified by them (Halliwell, 1992). It was recently suggested that catalase was the main hydrogen peroxidase activity in astrocytes and that it protected neighboring neurons (Desagher et al., 1996). In other studies of cultured astrocytes, both GSHPx and catalase were shown to be complementary in detoxification of H₂O₂ (Dringen and Hamprecht, 1997). Inhibitors of either enzyme only marginally reduced the rate of disappearance of H₂O₂ from the incubation media, however inhibition of both enzymes strongly reduced H₂O₂ clearance. It therefore appears that both H₂O₂ detoxifying systems can increase H₂O₂ clearance sufficiently under physiological conditions to prevent toxicity. This is not the case with other free radical scavengers such as manganese superoxide dismutase, in which a deficiency leads to premature death with both cardiac and CNS damage (Li et al., 1995; Lebovitz et al., 1996).

We, however, wondered whether GSHPx may play a more critical role under conditions in which neuronal metabolism is stressed by mitochondrial toxins. Both malonate and 3-NP are succinate dehydrogenase inhibitors that produce striatal lesions in vivo after either local striatal or systemic administration, respectively. Studies using ¹³C magnetic resonance spectroscopy showed that 3-NP preferentially inhibits oxidative metabolism in GABAergic neurons in vivo, whereas astrocyte metabolism was spared (Hassel and Sonnewald, 1995). The neurotoxicity of these compounds is associated with increases in OH generation as assessed by the salicylate-trapping method, as well as with increases in 3-NT, a marker of peroxynitrite (Schulz et al., 1995c). Similarly, MPTP neurotoxicity is associated with increases in OH generation and 3-NT (Schulz et al., 1995a). In the present study we therefore examined whether GSHPx knock-out mice would show increased susceptibility to these toxins.

The intrastriatal administration of malonate resulted in a significant twofold increase in lesion volume in GSHPx knock-out mice, as compared with both heterozygote GSHPx knock-out and wild-type control mice. Furthermore, the administration of malonate resulted in increased OH generation, as assessed using the salicylate-trapping method in homozygous GSHPx knock-out mice, as compared with both heterozygote GSHPx knock-out and wild-type control mice. The heterozygote GSHPx knock-out mice were produced by crossing the homozygous GSHPx knock-out mice with the background strain, which should control for any genetic variation between the GHSPx knock-out mice and the original background strain. 3-Nitropropionic acid lesions were also significantly greater in GSHPx knock-out mice. Lastly, MPTP neurotoxicity, as assessed by levels of dopamine, DOPAC, and HVA, was markedly exacerbated in the GSHPx knock-out mice.

GSHPx may therefore play an important role in initially compensating for increased generation of oxidants in these illnesses. GSHPx can detoxify reactive oxygen species by catalyzing the conversion of H₂O₂ to H₂O, but it also acts to reduce lysophospholipid hydroperoxides (Marinho et al., 1997; Fisher et al., 1999). Its role in detoxification of peroxynitrite (Sies et al., 1997) may be particularly crucial, because we and others found that inhibitors of neuronal nitric oxide synthase block malonate, 3-NP, and MPTP neurotoxicity (Schulz et al., 1995a; Hantraye et al., 1996; Przedborski et al., 1996). In the present study we found that striatal 3-NT concentrations were significantly increased after MPTP administration in GSHPx knock-out mice as compared with controls. We also found that increases in striatal 3-NT after systemic administration of 3-NP were significantly greater in GSHPx knock-out mice as compared with controls. This evidence therefore indicates that GSHPx plays an important role in the detoxification of peroxynitrite in vivo.

These results therefore indicate that although other free radical scavenging mechanisms are able to compensate for a loss of GSHPx under physiological conditions, they are inadequate in response to a metabolic stress. This has important implications for the pathogenesis of Huntington's disease (HD) and Parkinson's disease (PD). In both of these neurodegenerative diseases there is strong evidence implicating deficient energy production and increased free radical production (Beal, 1997). In HD there are increases in cerebral lactate in vivo, as assessed by magnetic resonance spectroscopy (Jenkins et al., 1993), decreases in mitochondrial complex II-III activity in postmortem tissue, and increased oxidative damage to DNA (Gu et al., 1996; Browne et al., 1997). In PD, several authors found reduced mitochondrial complex I activity in the substantia nigra and in platelets and evidence of increased oxidative damage (for review, see Beal, 1995). GSH is significantly depleted in the substantia nigra of PD patients, as well as in incidental Lewy body disease, which may be a presymptomatic stage of PD (Dexter et al., 1994). GSHPx activity is also reduced in the substantia nigra of PD patients (Ambani et al., 1975; Kish et al., 1985).

In PD it is possible that a latent genetic defect in free radical scavenging enzymes or in mitochondrial electron enzymes may be compensated under physiological conditions, but may increase susceptibility to environmental toxins. Environmental factors could also contribute to some of the variance in age of onset of HD (Gusella et al., 1997). The present results are therefore consistent with the possibility that genetic defects may interact with environmental toxins in the pathogenesis of neurodegenerative diseases.

	FOOTNOTES

Received Aug. 31, 1999; accepted Oct. 8, 1999.

This work was supported by National Institutes of Health Grants NS16367, NS10828, NS31579, and AG11337 (M.F.B.), NS37102 and NS35255 (R.J.F.), the Veterans Administration (R.J.F.), and the American Parkinson's Disease Association (R.J.F.). The secretarial assistance of Sharon Melanson is gratefully acknowledged.

Correspondence should be addressed to Dr. M. Flint Beal, Neurology Service/WRN 408, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114. E-mail: beal{at}helix.mgh.harvard.edu.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

• Ambani LM, Van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32:114-118[Abstract/Free Full Text].
• Andersen JK, Mo. JQ, Lee FY, Harnish P, Hamill RW, McNeill TH (1996) Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J Neurochem 67:2164-2171[Web of Science][Medline].
• Beal MF (1995) Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366[Web of Science][Medline].
• Beal MF (1997) Oxidative damage in neurodegenerative diseases. The Neuroscientist 3:21-27.
• Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB (1989) Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3:38-47[Web of Science][Medline].
• Beal MF, Matson WR, Swartz KJ, Gamache PH, Bird ED (1990) Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 55:1327-1339[Web of Science][Medline].
• Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT (1993a) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61:1147-1150[Web of Science][Medline].
• Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman B (1993b) Neurochemical and histologic characterization of excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4191[Abstract].
• Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308[Abstract/Free Full Text].
• Bloem BR, Irwin I, Buruma OJS, Haan J, Roos RAC, Tetrud JW, Langston JW (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci 97:273-293[Web of Science][Medline].
• Boveris A, Chance B (1973) The mitochondrial generation of hydrogen peroxide. Biochem J 134:707-716[Web of Science][Medline].
• Brannan TS, Maker HS, Raes IP (1981) Regional distribution of catalase in the adult rat brain. J Neurochem 36:307-309[Web of Science][Medline].
• Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MMK, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646-653[Web of Science][Medline].
• Chiueh CC, Krishna G, Tulsi P, Obata T, Lang K, Huang S-J, Murphy DL (1992) Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP⁺. Free Radic Biol Med 13:581-583[Web of Science][Medline].
• Copin JC, Ledig M, Tholey G (1992) Free radical scavenging systems of rat astroglial cells in primary culture: effect of anoxia and drug treatment. Neurochem Res 17:677-682[Web of Science][Medline].
• Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-700[Abstract/Free Full Text].
• Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52:1-6[Web of Science][Medline].
• Desagher S, Glowinski J, Premont J (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553-2562[Abstract/Free Full Text].
• Dexter DT, Sian J, Rose S, Hindmarsch JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35:38-44[Web of Science][Medline].
• Dringen R, Hamprecht B (1997) Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res 759:67-75[Web of Science][Medline].
• Fisher AB, Dodia C, Manevich Y, Chen JW, Feinstein SI (1999) Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J Biol Chem 274:21326-21334[Abstract/Free Full Text].
• Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods 10:221-235[Web of Science][Medline].
• Fridovich I (1989) Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 264:7761-7764[Free Full Text].
• Gaunt GL, De Duve C (1976) Subcellular distribution of D-amino acid oxidase and catalase in rat brain. J Neurochem 26:749-759[Web of Science][Medline].
• Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AHV (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385-389[Web of Science][Medline].
• Gusella JF, Persichetti F, MacDonald ME (1997) The genetic defect causing Huntington's disease: repeated in other contexts? Mol Med 3:238-246[Web of Science][Medline].
• Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623[Web of Science][Medline].
• Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2:1017-1021[Web of Science][Medline].
• Hasegawa E, Takeshige K, Oishi T, Murai Y, Minakami S (1990) 1-Methyl-4-phenylpyridinium (MPP⁺) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049-1055[Web of Science][Medline].
• Hassel B, Sonnewald U (1995) Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J Neurochem 65:1184-1191[Web of Science][Medline].
• Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, Sugawara M, Frank CD (1997) Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272:16644-16651[Abstract/Free Full Text].
• Huang H-C, Lee EHY (1998) MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24:76-84[Web of Science][Medline].
• Huang J, Philbert MA (1995) Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res 680:16-22[Web of Science][Medline].
• Jain A, Martensson J, Stole E, Auld PAM, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88:1913-1917[Abstract/Free Full Text].
• Jenkins B, Koroshetz W, Beal MF, Rosen B (1993) Evidence for an energy metabolism defect in Huntington's disease using localized proton spectroscopy. Neurology 43:2689-2695[Abstract/Free Full Text].
• Jurma OP, Hom DG, Andersen JK (1997) Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic Biol Med 23:1055-1066[Web of Science][Medline].
• Kish SJ, Morito C, Hornykiewicz O (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett 58:343-346[Web of Science][Medline].
• Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71:952-958[Web of Science][Medline].
• Lebovitz RM, Zhang H, Vogel H, Cartwright J, J, Dionne L, Lu N, Huang S, Matzuk MM (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93:9782-9787[Abstract/Free Full Text].
• Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376-381[Web of Science][Medline].
• Marinho HS, Antunes F, Pinto RE (1997) Role of glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase in the reduction of lysophospholipid hydroperoxides. Free Radic Biol Med 22:871-883[Web of Science][Medline].
• Martinez M, Ferrandiz ML, Diez A, Miquel J (1995) Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice. Mech Ageing Dev 84:77-81[Web of Science][Medline].
• Mizui T, Kinouchi H, Chan PH (1992) Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol 262:H313-H317[Abstract/Free Full Text].
• Nakamura K, Wang W, Kang UJ (1997) The role of glutathione in dopaminergic neuronal survival. J Neurochem 69:1850-1858[Web of Science][Medline].
• Olanow CW (1993) A radical hypothesis for neuronal degeneration. Trends Neurosci 16:439-443[Web of Science][Medline].
• Pileblad E, Magnuson T, Fornstedt B (1989) Reduction of brain glutathione by [SCAP]L[R]-buthionine sulfoximine potentiates the dopamine-depletion action of 6-hydroxydopamine in rat striatum. J Neurochem 52:978-980[Web of Science][Medline].
• Przedborski S, Jackon-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571[Abstract/Free Full Text].
• Raps SP, Lai JCK, Hertz L, Cooper AJL (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493:398-401[Web of Science][Medline].
• Schulz JB, Henshaw DR, Matthews RT, Beal MF (1995a) Coenzyme Q₁₀ and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp Neurol 132:279-283[Web of Science][Medline].
• Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF (1995b) Involvement of free radicals in excitotoxicity in vivo. J Neurochem 64:2239-2247[Web of Science][Medline].
• Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, Beal MF (1995c) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15:8419-8429[Abstract].
• Sies H, Sharov VS, Klotz L-O, Briviba K (1997) Glutathione peroxidase protects against peroxynitrite-mediated oxidations. J Biol Chem 272:27812-27817[Abstract/Free Full Text].
• Slivka A, Mytilineou C, Cohen G (1987) Histochemical evaluation of glutathione in brain. Brain Res 409:275-284[Web of Science][Medline].
• Sriram K, Pai KS, Boyd MR, Ravindranath V (1997) Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res 749:44-52[Web of Science][Medline].
• Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191-1206[Web of Science][Medline].
• Trepanier G, Furling D, Puymirat J, Mirault M-E (1996) Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience 75:231-243[Web of Science][Medline].
• Vitorica J, Machado A, Satrustegui J (1984) Age-dependent variations in peroxide-utilizing enzymes from rat brain mitochondria and cytoplasm. J Neurochem 42:351-357[Web of Science][Medline].
• Wullner U, Loschmann P-A, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, Klockgether T (1996) Glutathione depletion potentiates MPTP and MPP⁺ toxicity in nigral dopaminergic neurones. NeuroReport 7:921-923[Web of Science][Medline].

---

Copyright © 2000 Society for Neuroscience  0270-6474/0/2011-07$05.00/0

This article has been cited by other articles:

				M. Kokubo, M. Nishio, T. J. Ribar, K. A. Anderson, A. E. West, and A. R. Means BDNF-Mediated Cerebellar Granule Cell Development Is Impaired in Mice Null for CaMKK2 or CaMKIV J. Neurosci., July 15, 2009; 29(28): 8901 - 8913. [Abstract] [Full Text] [PDF]

				J.-W. Yang, I. L. Hanganu-Opatz, J.-J. Sun, and H. J. Luhmann Three Patterns of Oscillatory Activity Differentially Synchronize Developing Neocortical Networks In Vivo J. Neurosci., July 15, 2009; 29(28): 9011 - 9025. [Abstract] [Full Text] [PDF]

				J. C. Patel, P. Witkovsky, M. V. Avshalumov, and M. E. Rice Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release J. Neurosci., May 20, 2009; 29(20): 6568 - 6579. [Abstract] [Full Text] [PDF]

				L. Saavedra-Rodriguez, A. Vazquez, H. G. Ortiz-Zuazaga, N. E. Chorna, F. A. Gonzalez, L. Andres, K. Rodriguez, F. Ramirez, A. Rodriguez, and S. P. de Ortiz Identification of Flap Structure-Specific Endonuclease 1 as a Factor Involved in Long-Term Memory Formation of Aversive Learning J. Neurosci., May 6, 2009; 29(18): 5726 - 5737. [Abstract] [Full Text] [PDF]

				W. Francesconi, F. Berton, V. Repunte-Canonigo, K. Hagihara, D. Thurbon, D. Lekic, S. E. Specio, T. N. Greenwell, S. A. Chen, K. C. Rice, et al. Protracted Withdrawal from Alcohol and Drugs of Abuse Impairs Long-Term Potentiation of Intrinsic Excitability in the Juxtacapsular Bed Nucleus of the Stria Terminalis J. Neurosci., April 29, 2009; 29(17): 5389 - 5401. [Abstract] [Full Text] [PDF]

				Z. Qi and P. E. Gold Intrahippocampal infusions of anisomycin produce amnesia: Contribution of increased release of norepinephrine, dopamine, and acetylcholine Learn. Mem., April 29, 2009; 16(5): 308 - 314. [Abstract] [Full Text] [PDF]

				K. Emmorey, R. Thompson, and R. Colvin Eye Gaze During Comprehension of American Sign Language by Native and Beginning Signers J. Deaf Stud. Deaf Educ., April 1, 2009; 14(2): 237 - 243. [Abstract] [Full Text] [PDF]

				D. A. Copland, K. L. McMahon, P. A. Silburn, and G. I. de Zubicaray Dopaminergic Neuromodulation of Semantic Processing: A 4-T fMRI Study with Levodopa Cereb Cortex, March 25, 2009; (2009) bhp017v1. [Abstract] [Full Text] [PDF]

				W.-Y. Xie, Y. He, Y.-R. Yang, Y.-F. Li, K. Kang, B.-M. Xing, and Y. Wang Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the {delta}-Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance J. Neurosci., March 18, 2009; 29(11): 3551 - 3564. [Abstract] [Full Text] [PDF]

				A. Goncalves DaSilva and V. W. Yong Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation Am. J. Pathol., March 1, 2009; 174(3): 898 - 909. [Abstract] [Full Text] [PDF]

				D. Thevarajah, A. Mikulic, and M. C. Dorris Role of the Superior Colliculus in Choosing Mixed-Strategy Saccades J. Neurosci., February 18, 2009; 29(7): 1998 - 2008. [Abstract] [Full Text] [PDF]

				B. L. Whitsel, O. V. Favorov, Y. Li, M. Quibrera, and M. Tommerdahl Area 3a Neuron Response to Skin Nociceptor Afferent Drive Cereb Cortex, February 1, 2009; 19(2): 349 - 366. [Abstract] [Full Text] [PDF]

				M. H. Hennig, C. Adams, D. Willshaw, and E. Sernagor Early-Stage Waves in the Retinal Network Emerge Close to a Critical State Transition between Local and Global Functional Connectivity J. Neurosci., January 28, 2009; 29(4): 1077 - 1086. [Abstract] [Full Text] [PDF]

				N. Mamiya, H. Fukushima, A. Suzuki, Z. Matsuyama, S. Homma, P. W. Frankland, and S. Kida Brain Region-Specific Gene Expression Activation Required for Reconsolidation and Extinction of Contextual Fear Memory J. Neurosci., January 14, 2009; 29(2): 402 - 413. [Abstract] [Full Text] [PDF]

				L. C. Lyons and G. Roman Circadian modulation of short-term memory in Drosophila Learn. Mem., December 30, 2008; 16(1): 19 - 27. [Abstract] [Full Text] [PDF]

				C. Paul, F. Schoberl, P. Weinmeister, V. Micale, C. T. Wotjak, F. Hofmann, and T. Kleppisch Signaling through cGMP-Dependent Protein Kinase I in the Amygdala Is Critical for Auditory-Cued Fear Memory and Long-Term Potentiation J. Neurosci., December 24, 2008; 28(52): 14202 - 14212. [Abstract] [Full Text] [PDF]

				M. N. Miller, B. W. Okaty, and S. B. Nelson Region-Specific Spike-Frequency Acceleration in Layer 5 Pyramidal Neurons Mediated by Kv1 Subunits J. Neurosci., December 17, 2008; 28(51): 13716 - 13726. [Abstract] [Full Text] [PDF]

				N. Cougot, S. N. Bhattacharyya, L. Tapia-Arancibia, R. Bordonne, W. Filipowicz, E. Bertrand, and F. Rage Dendrites of Mammalian Neurons Contain Specialized P-Body-Like Structures That Respond to Neuronal Activation J. Neurosci., December 17, 2008; 28(51): 13793 - 13804. [Abstract] [Full Text] [PDF]

				J. A. Lamoureux, W. H. Meck, and C. L. Williams Prenatal choline availability alters the context sensitivity of Pavlovian conditioning in adult rats Learn. Mem., December 2, 2008; 15(12): 866 - 875. [Abstract] [Full Text] [PDF]

				R. K. Bachtell and D. W. Self Renewed Cocaine Exposure Produces Transient Alterations in Nucleus Accumbens AMPA Receptor-Mediated Behavior J. Neurosci., November 26, 2008; 28(48): 12808 - 12814. [Abstract] [Full Text] [PDF]

				S. C. Harney, D. E. Jane, and R. Anwyl Extrasynaptic NR2D-Containing NMDARs Are Recruited to the Synapse during LTP of NMDAR-EPSCs J. Neurosci., November 5, 2008; 28(45): 11685 - 11694. [Abstract] [Full Text] [PDF]

				K. T. Ota, V. J. Pierre, J. E. Ploski, K. Queen, and G. E. Schafe The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase Learn. Mem., October 2, 2008; 15(10): 792 - 805. [Abstract] [Full Text] [PDF]

				H. Fukushima, R. Maeda, R. Suzuki, A. Suzuki, M. Nomoto, H. Toyoda, L.-J. Wu, H. Xu, M.-G. Zhao, K. Ueda, et al. Upregulation of Calcium/Calmodulin-Dependent Protein Kinase IV Improves Memory Formation and Rescues Memory Loss with Aging J. Neurosci., October 1, 2008; 28(40): 9910 - 9919. [Abstract] [Full Text] [PDF]

				A. Bollimunta, Y. Chen, C. E. Schroeder, and M. Ding Neuronal Mechanisms of Cortical Alpha Oscillations in Awake-Behaving Macaques J. Neurosci., October 1, 2008; 28(40): 9976 - 9988. [Abstract] [Full Text] [PDF]

				G. Akopian, C. Crawford, M. F. Beal, M. Cappelletti, M. W. Jakowec, G. M. Petzinger, L. Zheng, S. L. Gheorghe, C. M. Reichel, R. Chow, et al. Decreased Striatal Dopamine Release Underlies Increased Expression of Long-Term Synaptic Potentiation at Corticostriatal Synapses 24 h after 3-Nitropropionic-Acid-Induced Chemical Hypoxia J. Neurosci., September 17, 2008; 28(38): 9585 - 9597. [Abstract] [Full Text] [PDF]

				B. A. Grueter, Z. A. McElligott, A. J. Robison, G. C. Mathews, and D. G. Winder In Vivo Metabotropic Glutamate Receptor 5 (mGluR5) Antagonism Prevents Cocaine-Induced Disruption of Postsynaptically Maintained mGluR5-Dependent Long-Term Depression J. Neurosci., September 10, 2008; 28(37): 9261 - 9270. [Abstract] [Full Text] [PDF]

				Y. I. Alexandrov How we fragment the world: the view from inside versus the view from outside Social Science Information, September 1, 2008; 47(3): 419 - 457. [Abstract] [PDF]

				M. A. Sullivan, H. Chen, and H. Morikawa Recurrent Inhibitory Network among Striatal Cholinergic Interneurons J. Neurosci., August 27, 2008; 28(35): 8682 - 8690. [Abstract] [Full Text] [PDF]

				J. Van Der Werf, O. Jensen, P. Fries, and W. P. Medendorp Gamma-Band Activity in Human Posterior Parietal Cortex Encodes the Motor Goal during Delayed Prosaccades and Antisaccades J. Neurosci., August 20, 2008; 28(34): 8397 - 8405. [Abstract] [Full Text] [PDF]

				M. Shabat-Simon, D. Levy, A. Amir, M. Rehavi, and A. Zangen Dissociation between Rewarding and Psychomotor Effects of Opiates: Differential Roles for Glutamate Receptors within Anterior and Posterior Portions of the Ventral Tegmental Area J. Neurosci., August 20, 2008; 28(34): 8406 - 8416. [Abstract] [Full Text] [PDF]

				J. Sfondouris, L. Rajagopalan, F. A. Pereira, and W. E. Brownell Membrane Composition Modulates Prestin-associated Charge Movement J. Biol. Chem., August 15, 2008; 283(33): 22473 - 22481. [Abstract] [Full Text] [PDF]

				J. Turchi, D. Buffalari, and M. Mishkin Double dissociation of pharmacologically induced deficits in visual recognition and visual discrimination learning Learn. Mem., August 6, 2008; 15(8): 565 - 568. [Abstract] [Full Text] [PDF]

				A. Mazaheri and O. Jensen Asymmetric Amplitude Modulations of Brain Oscillations Generate Slow Evoked Responses J. Neurosci., July 30, 2008; 28(31): 7781 - 7787. [Abstract] [Full Text] [PDF]

				K. Shibata, N. Yamagishi, N. Goda, T. Yoshioka, O. Yamashita, M.-a. Sato, and M. Kawato The Effects of Feature Attention on Prestimulus Cortical Activity in the Human Visual System Cereb Cortex, July 1, 2008; 18(7): 1664 - 1675. [Abstract] [Full Text] [PDF]

				C. M. Dodds, U. Muller, L. Clark, A. van Loon, R. Cools, and T. W. Robbins Methylphenidate Has Differential Effects on Blood Oxygenation Level-Dependent Signal Related to Cognitive Subprocesses of Reversal Learning J. Neurosci., June 4, 2008; 28(23): 5976 - 5982. [Abstract] [Full Text] [PDF]

				T. M. Kauppinen, Y. Higashi, S. W. Suh, C. Escartin, K. Nagasawa, and R. A. Swanson Zinc Triggers Microglial Activation J. Neurosci., May 28, 2008; 28(22): 5827 - 5835. [Abstract] [Full Text] [PDF]

				P. Fries, T. Womelsdorf, R. Oostenveld, and R. Desimone The Effects of Visual Stimulation and Selective Visual Attention on Rhythmic Neuronal Synchronization in Macaque Area V4 J. Neurosci., April 30, 2008; 28(18): 4823 - 4835. [Abstract] [Full Text] [PDF]

				K. B. MADDOX, D. N. RAPP, S. BRION, and H. A. TAYLOR Social influences on spatial memory Mem Cognit, April 1, 2008; 36(3): 479 - 494. [Abstract] [PDF]

				M. J. Krashes and S. Waddell Rapid Consolidation to a radish and Protein Synthesis-Dependent Long-Term Memory after Single-Session Appetitive Olfactory Conditioning in Drosophila J. Neurosci., March 19, 2008; 28(12): 3103 - 3113. [Abstract] [Full Text] [PDF]

				J. J. Hwang, S.-J. Lee, T.-Y. Kim, J.-H. Cho, and J.-Y. Koh Zinc and 4-Hydroxy-2-Nonenal Mediate Lysosomal Membrane Permeabilization Induced by H2O2 in Cultured Hippocampal Neurons J. Neurosci., March 19, 2008; 28(12): 3114 - 3122. [Abstract] [Full Text] [PDF]

				R. T. LaLumiere and P. W. Kalivas Glutamate Release in the Nucleus Accumbens Core Is Necessary for Heroin Seeking J. Neurosci., March 19, 2008; 28(12): 3170 - 3177. [Abstract] [Full Text] [PDF]

				V. Wyart and C. Tallon-Baudry Neural Dissociation between Visual Awareness and Spatial Attention J. Neurosci., March 5, 2008; 28(10): 2667 - 2679. [Abstract] [Full Text] [PDF]

				J. R. Bergado-Acosta, S. Sangha, R. T. Narayanan, K. Obata, H.-C. Pape, and O. Stork Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory Learn. Mem., March 5, 2008; 15(3): 163 - 171. [Abstract] [Full Text] [PDF]

				K. Sasaki, J. Jing, M. R. Due, and K. R. Weiss An Input-Representing Interneuron Regulates Spike Timing and Thereby Phase Switching in a Motor Network J. Neurosci., February 20, 2008; 28(8): 1916 - 1928. [Abstract] [Full Text] [PDF]

				M. T. Alkire, R. Gruver, J. Miller, J. R. McReynolds, E. L. Hahn, and L. Cahill Neuroimaging analysis of an anesthetic gas that blocks human emotional memory PNAS, February 5, 2008; 105(5): 1722 - 1727. [Abstract] [Full Text] [PDF]

				I. Hurwitz, A. Ophir, A. Korngreen, J. Koester, and A. J. Susswein Currents Contributing to Decision Making in Neurons B31/B32 of Aplysia J Neurophysiol, February 1, 2008; 99(2): 814 - 830. [Abstract] [Full Text] [PDF]

				D. Mueller, J. T. Porter, and G. J. Quirk Noradrenergic Signaling in Infralimbic Cortex Increases Cell Excitability and Strengthens Memory for Fear Extinction J. Neurosci., January 9, 2008; 28(2): 369 - 375. [Abstract] [Full Text] [PDF]

				W. A. C. Bloomer, H. M. A. VanDongen, and A. M. J. VanDongen Arc/Arg3.1 Translation Is Controlled by Convergent N-Methyl-D-aspartate and Gs-coupled Receptor Signaling Pathways J. Biol. Chem., January 4, 2008; 283(1): 582 - 592. [Abstract] [Full Text] [PDF]

				L. Song, J. McGee, and E. J. Walsh Development of Cochlear Amplification, Frequency Tuning, and Two-Tone Suppression in the Mouse J Neurophysiol, January 1, 2008; 99(1): 344 - 355. [Abstract] [Full Text] [PDF]

				S. M. Daselaar, H. J. Rice, D. L. Greenberg, R. Cabeza, K. S. LaBar, and D. C. Rubin The Spatiotemporal Dynamics of Autobiographical Memory: Neural Correlates of Recall, Emotional Intensity, and Reliving Cereb Cortex, January 1, 2008; 18(1): 217 - 229. [Abstract] [Full Text] [PDF]

				D. Levy, M. Shabat-Simon, U. Shalev, N. Barnea-Ygael, A. Cooper, and A. Zangen Repeated Electrical Stimulation of Reward-Related Brain Regions Affects Cocaine But Not "Natural" Reinforcement J. Neurosci., December 19, 2007; 27(51): 14179 - 14189. [Abstract] [Full Text] [PDF]

				M. A. Retamal, N. Froger, N. Palacios-Prado, P. Ezan, P. J. Saez, J. C. Saez, and C. Giaume Cx43 Hemichannels and Gap Junction Channels in Astrocytes Are Regulated Oppositely by Proinflammatory Cytokines Released from Activated Microglia J. Neurosci., December 12, 2007; 27(50): 13781 - 13792. [Abstract] [Full Text] [PDF]

				R. D. Bland, L. M. Mokres, R. Ertsey, B. E. Jacobson, S. Jiang, M. Rabinovitch, L. Xu, E. S. Shinwell, F. Zhang, and M. A. Beasley Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1099 - L1110. [Abstract] [Full Text] [PDF]

				G. van Wingen, F. van Broekhoven, R. J. Verkes, K. M. Petersson, T. Backstrom, J. Buitelaar, and G. Fernandez How Progesterone Impairs Memory for Biologically Salient Stimuli in Healthy Young Women J. Neurosci., October 17, 2007; 27(42): 11416 - 11423. [Abstract] [Full Text] [PDF]

				J. Hirayama, S. Cho, and P. Sassone-Corsi Circadian control by the reduction/oxidation pathway: Catalase represses light-dependent clock gene expression in the zebrafish PNAS, October 2, 2007; 104(40): 15747 - 15752. [Abstract] [Full Text] [PDF]

				A. A. Gibbs, K. H. Naudts, E. P. Spencer, and A. S. David The Role of Dopamine in Attentional and Memory Biases for Emotional Information Am J Psychiatry, October 1, 2007; 164(10): 1603 - 1609. [Abstract] [Full Text] [PDF]

				C. E. Canal, Q. Chang, and P. E. Gold Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor PNAS, July 24, 2007; 104(30): 12500 - 12505. [Abstract] [Full Text] [PDF]

				M. Niwa, A. Nitta, H. Mizoguchi, Y. Ito, Y. Noda, T. Nagai, and T. Nabeshima A Novel Molecule "Shati" Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference J. Neurosci., July 11, 2007; 27(28): 7604 - 7615. [Abstract] [Full Text] [PDF]

				M. Korvorst, H.-C. Nuerk, and K. Willmes The Hands Have It: Number Representations in Adult Deaf Signers J. Deaf Stud. Deaf Educ., July 1, 2007; 12(3): 362 - 372. [Abstract] [Full Text] [PDF]

				E. Santini, E. Valjent, A. Usiello, M. Carta, A. Borgkvist, J.-A. Girault, D. Herve, P. Greengard, and G. Fisone Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia J. Neurosci., June 27, 2007; 27(26): 6995 - 7005. [Abstract] [Full Text] [PDF]

				M. Johansson, A. Aslan, K.-H. Bauml, A. Gabel, and A. Mecklinger When Remembering Causes Forgetting: Electrophysiological Correlates of Retrieval-Induced Forgetting Cereb Cortex, June 1, 2007; 17(6): 1335 - 1341. [Abstract] [Full Text] [PDF]

				J. W. Elias and M. V. Wagster Developing Context and Background Underlying Cognitive Intervention/Training Studies in Older Populations J. Gerontol. B. Psychol. Sci. Soc. Sci., June 1, 2007; 62(suppl_Special_Issue_1): 5 - 10. [Abstract] [Full Text] [PDF]

				L. M. Ramer, L. T. McPhail, J. F. Borisoff, L. J. J. Soril, T. K. Y. Kaan, J. H. T. Lee, J. W. T. Saunders, L. P. R. Hwi, and M. S. Ramer Endogenous TrkB Ligands Suppress Functional Mechanosensory Plasticity in the Deafferented Spinal Cord J. Neurosci., May 23, 2007; 27(21): 5812 - 5822. [Abstract] [Full Text] [PDF]

				M. C. Dorris, E. Olivier, and D. P. Munoz Competitive Integration of Visual and Preparatory Signals in the Superior Colliculus during Saccadic Programming J. Neurosci., May 9, 2007; 27(19): 5053 - 5062. [Abstract] [Full Text] [PDF]

				C. Geisler, D. Robbe, M. Zugaro, A. Sirota, and G. Buzsaki Hippocampal place cell assemblies are speed-controlled oscillators PNAS, May 8, 2007; 104(19): 8149 - 8154. [Abstract] [Full Text] [PDF]

				P. C. Hauser, J. Cohen, M. W. G. Dye, and D. Bavelier Visual Constructive and Visual-Motor Skills in Deaf Native Signers J. Deaf Stud. Deaf Educ., April 1, 2007; 12(2): 148 - 157. [Abstract] [Full Text] [PDF]

				D. Jokisch and O. Jensen Modulation of Gamma and Alpha Activity during a Working Memory Task Engaging the Dorsal or Ventral Stream J. Neurosci., March 21, 2007; 27(12): 3244 - 3251. [Abstract] [Full Text] [PDF]

				M. Smeyne, J. Boyd, K. Raviie Shepherd, Y. Jiao, B. B. Pond, M. Hatler, R. Wolf, C. Henderson, and R. J. Smeyne GST{pi} expression mediates dopaminergic neuron sensitivity in experimental parkinsonism PNAS, February 6, 2007; 104(6): 1977 - 1982. [Abstract] [Full Text] [PDF]

				S. V. David, B. Y. Hayden, and J. L. Gallant Spectral Receptive Field Properties Explain Shape Selectivity in Area V4 J Neurophysiol, December 1, 2006; 96(6): 3492 - 3505. [Abstract] [Full Text] [PDF]

				Y. M. Choi, S. H. Kim, S. Chung, D. Y. Uhm, and M. K. Park Regional Interaction of Endoplasmic Reticulum Ca2+ Signals between Soma and Dendrites through Rapid Luminal Ca2+ Diffusion. J. Neurosci., November 22, 2006; 26(47): 12127 - 12136. [Abstract] [Full Text] [PDF]

				Y. Kaga, W. J. Shoemaker, M. Furusho, M. Bryant, J. Rosenbluth, S. E. Pfeiffer, L. Oh, M. Rasband, C. Lappe-Siefke, K. Yu, et al. Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation. J. Neurosci., November 22, 2006; 26(47): 12339 - 12350. [Abstract] [Full Text] [PDF]

				J. Peng, L. Xie, F. F. Stevenson, S. Melov, D. A. Di Monte, and J. K. Andersen Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration. J. Neurosci., November 8, 2006; 26(45): 11644 - 11651. [Abstract] [Full Text] [PDF]

				Y. Shen, D. Yu, H. Hiel, P. Liao, D. T. Yue, P. A. Fuchs, and T. W. Soong Alternative Splicing of the CaV1.3 Channel IQ Domain, a Molecular Switch for Ca2+-Dependent Inactivation within Auditory Hair Cells. J. Neurosci., October 18, 2006; 26(42): 10690 - 10699. [Abstract] [Full Text] [PDF]

				D. Billups, B. Billups, R. A. J. Challiss, and S. R. Nahorski Modulation of Gq-Protein-Coupled Inositol Trisphosphate and Ca2+ Signaling by the Membrane Potential J. Neurosci., September 27, 2006; 26(39): 9983 - 9995. [Abstract] [Full Text] [PDF]

				G. Thut, A. Nietzel, S. A. Brandt, and A. Pascual-Leone {alpha}-Band Electroencephalographic Activity over Occipital Cortex Indexes Visuospatial Attention Bias and Predicts Visual Target Detection J. Neurosci., September 13, 2006; 26(37): 9494 - 9502. [Abstract] [Full Text] [PDF]

				L. Madhavan, V. Ourednik, and J. Ourednik Increased "Vigilance" of Antioxidant Mechanisms in Neural Stem Cells Potentiates Their Capability to Resist Oxidative Stress Stem Cells, September 1, 2006; 24(9): 2110 - 2119. [Abstract] [Full Text] [PDF]

				S. S. Das and G. A. Banker The Role of Protein Interaction Motifs in Regulating the Polarity and Clustering of the Metabotropic Glutamate Receptor mGluR1a J. Neurosci., August 2, 2006; 26(31): 8115 - 8125. [Abstract] [Full Text] [PDF]

				A. S. Adewale, D. M. Platt, and R. D. Spealman Pharmacological Stimulation of Group II Metabotropic Glutamate Receptors Reduces Cocaine Self-Administration and Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 922 - 931. [Abstract] [Full Text] [PDF]

				L. A. Snook, G. Milligan, B. L. Kieffer, and D. Massotte {micro}-{delta} Opioid Receptor Functional Interaction: Insight Using Receptor-G Protein Fusions J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 683 - 690. [Abstract] [Full Text] [PDF]

				E. M. Schuman, J. L. Dynes, and O. Steward Synaptic regulation of translation of dendritic mRNAs. J. Neurosci., July 5, 2006; 26(27): 7143 - 7146. [Abstract] [Full Text] [PDF]

				R. Bull, G. Blatto-Vallee, and M. Fabich Subitizing, Magnitude Representation, and Magnitude Retrieval in Deaf and Hearing Adults J. Deaf Stud. Deaf Educ., July 1, 2006; 11(3): 289 - 302. [Abstract] [Full Text] [PDF]

				V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic Choline Transport for Phospholipid Synthesis. Experimental Biology and Medicine, May 1, 2006; 231(5): 490 - 504. [Abstract] [Full Text] [PDF]

				R. Mejias, J. Villadiego, C. O. Pintado, P. J. Vime, L. Gao, J. J. Toledo-Aral, M. Echevarria, and J. Lopez-Barneo Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice. J. Neurosci., April 26, 2006; 26(17): 4500 - 4508. [Abstract] [Full Text] [PDF]

				V. L. Katanaev and A. Tomlinson Dual roles for the trimeric G protein Go in asymmetric cell division in Drosophila PNAS, April 25, 2006; 103(17): 6524 - 6529. [Abstract] [Full Text] [PDF]

				M. H. Milekic, S. D. Brown, C. Castellini, and C. M. Alberini Persistent disruption of an established morphine conditioned place preference. J. Neurosci., March 15, 2006; 26(11): 3010 - 3020. [Abstract] [Full Text] [PDF]

				O. Ibanez-Sandoval, A. Hernandez, B. Floran, E. Galarraga, D. Tapia, R. Valdiosera, D. Erlij, J. Aceves, and J. Bargas Control of the Subthalamic Innervation of Substantia Nigra Pars Reticulata by D1 and D2 Dopamine Receptors J Neurophysiol, March 1, 2006; 95(3): 1800 - 1811. [Abstract] [Full Text] [PDF]

				D. Golomb, E. Ahissar, and D. Kleinfeld Coding of Stimulus Frequency by Latency in Thalamic Networks Through the Interplay of GABAB-Mediated Feedback and Stimulus Shape J Neurophysiol, March 1, 2006; 95(3): 1735 - 1750. [Abstract] [Full Text] [PDF]

				X. Dai, X. Cao, and D. L. Kreulen Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1019 - H1026. [Abstract] [Full Text] [PDF]

				R. VanRullen, L. Reddy, and C. Koch The Continuous Wagon Wheel Illusion Is Associated with Changes in Electroencephalogram Power at ~13 Hz J. Neurosci., January 11, 2006; 26(2): 502 - 507. [Abstract] [Full Text] [PDF]

				Y.-H. Kim, M.-H. Ko, S.-Y. Na, S.-H. Park, and K.-W. Kim Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study Clinical Rehabilitation, January 1, 2006; 20(1): 24 - 30. [Abstract] [PDF]

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (96) Citing Articles via Google Scholar Google Scholar Articles by Klivenyi, P. Articles by Beal, M. F. Search for Related Content PubMed PubMed Citation Articles by Klivenyi, P. Articles by Beal, M. F.

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help